Yu Zhang

13.9k total citations · 1 hit paper
563 papers, 9.6k citations indexed

About

Yu Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Zhang has authored 563 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 272 papers in Molecular Biology, 176 papers in Cancer Research and 95 papers in Oncology. Recurrent topics in Yu Zhang's work include Cancer-related molecular mechanisms research (114 papers), MicroRNA in disease regulation (78 papers) and RNA modifications and cancer (63 papers). Yu Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (114 papers), MicroRNA in disease regulation (78 papers) and RNA modifications and cancer (63 papers). Yu Zhang collaborates with scholars based in China, United States and Australia. Yu Zhang's co-authors include Hua Lu, Shelya X. Zeng, Jun‐Ming Liao, Gang Chen, Fang Liu, Guowu Wang, Ran Chen, Daniel Nguyen, Yi Lü and Lan Cao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yu Zhang

518 papers receiving 9.5k citations

Hit Papers

Polyamine metabolite spermidine rejuvenates oocyte qualit... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Zhang China 48 5.4k 3.5k 1.4k 963 842 563 9.6k
Jing Zhang China 50 7.5k 1.4× 3.3k 0.9× 1.2k 0.9× 1.0k 1.1× 905 1.1× 511 11.1k
Yan Wang China 48 4.8k 0.9× 2.3k 0.7× 1.2k 0.9× 964 1.0× 718 0.9× 512 9.8k
Ying Liu China 53 5.6k 1.0× 2.4k 0.7× 1.0k 0.7× 803 0.8× 1.3k 1.5× 471 10.7k
Jing He China 47 5.7k 1.0× 3.1k 0.9× 1.4k 1.0× 825 0.9× 1.1k 1.3× 626 10.2k
Qian Zhang China 51 6.2k 1.1× 3.6k 1.0× 1.8k 1.3× 977 1.0× 1.1k 1.3× 472 11.4k
Cheng Wang China 60 7.0k 1.3× 5.2k 1.5× 939 0.7× 942 1.0× 688 0.8× 411 12.0k
Bin Liu China 48 4.8k 0.9× 1.9k 0.6× 1.3k 0.9× 1.2k 1.2× 760 0.9× 495 9.1k
Rui Chen China 57 7.3k 1.3× 3.6k 1.0× 1.4k 1.0× 962 1.0× 1.3k 1.6× 514 13.5k
Lili Li China 49 4.8k 0.9× 1.7k 0.5× 1.9k 1.3× 642 0.7× 756 0.9× 376 8.8k
Yang Yang China 54 6.0k 1.1× 2.0k 0.6× 1.4k 1.0× 803 0.8× 1.4k 1.6× 531 12.1k

Countries citing papers authored by Yu Zhang

Since Specialization
Citations

This map shows the geographic impact of Yu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zhang more than expected).

Fields of papers citing papers by Yu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zhang. The network helps show where Yu Zhang may publish in the future.

Co-authorship network of co-authors of Yu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Zhang. A scholar is included among the top collaborators of Yu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Zhang. Yu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhao, Jinxin, Yu Zhang, Meng Zhang, et al.. (2025). Revisiting therapeutic options against resistant klebsiella pneumoniae infection: Phage therapy is key. Microbiological Research. 293. 128083–128083. 4 indexed citations
3.
Wang, Wei, Yu Zhang, Qian Wu, et al.. (2025). Effect of population aging on pulmonary tuberculosis burden in Zhejiang Province, China: a population-based study. Frontiers in Public Health. 13. 1647139–1647139.
4.
Fu, Kun, et al.. (2025). Optimizing the Follow‐Up Interval After Successful Cold Knife Conization of CIN3: A 10‐Year Retrospective Cohort Study. Cancer Medicine. 14(7). e70825–e70825. 1 indexed citations
5.
Zhang, Yu, et al.. (2024). Effects of different nitric oxide synthases on pulmonary and systemic hemodynamics in hypoxic stress rat model. SHILAP Revista de lepidopterología. 8(2). 344–352.
6.
Liu, Mengjie, Chaofan Li, Jingkun Qu, et al.. (2023). Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes. Cancer Science. 114(10). 3834–3847. 12 indexed citations
7.
Lu, Yiting, Di Zhang, Xinchang Liu, et al.. (2023). Identification of a novel frameshift mutation in the SCNN1B causing Liddle syndrome. Science Bulletin. 68(4). 383–387. 3 indexed citations
8.
Shen, Xi, Siyu Yang, Jintao Fu, et al.. (2023). Diterpenoid Alkaloids from Delphinium ajacis and Their Anti‐inflammatory Activity. Chemistry & Biodiversity. 21(2). e202301958–e202301958. 2 indexed citations
9.
Chen, Xin, Yu Zhang, Yang Xu, et al.. (2023). Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer. Journal of Translational Medicine. 21(1). 296–296. 6 indexed citations
10.
Zhang, Yaohua, Xu‐Sheng Liu, Yan Gao, et al.. (2023). SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with 18F-FDG metabolic parameters. Lung Cancer. 188. 107449–107449. 5 indexed citations
11.
Wang, Xinyi, et al.. (2023). Deep Learning Radiomics Nomogram Based on Magnetic Resonance Imaging for Differentiating Type I/II Epithelial Ovarian Cancer. Academic Radiology. 31(6). 2391–2401. 12 indexed citations
12.
Wang, Jieqiong, Yajie Chen, Canhua Huang, et al.. (2021). Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth. Cancer Research. 81(15). 4041–4053. 13 indexed citations
13.
Fu, Kun, Ming Lei, Wenqing Yang, et al.. (2021). The treatment strategy of patients with positive margins after cervical cold knife conization—A 7‐year retrospective study in China. International Journal of Gynecology & Obstetrics. 156(1). 159–165. 5 indexed citations
14.
Li, Jie, Chaoyun Pan, Austin C. Boese, et al.. (2020). DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling. Clinical Cancer Research. 26(14). 3843–3855. 48 indexed citations
15.
Cheng, Xiang, Yu Zhang, Feifeng Song, et al.. (2020). URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Peng, You, et al.. (2020). MiR-146b-5p Regulates the Expression of Long Noncoding RNA MALAT1 and Its Effect on the Invasion and Proliferation of Papillary Thyroid Cancer. Cancer Biotherapy and Radiopharmaceuticals. 36(5). 433–440. 13 indexed citations
17.
Chen, Neng‐Hua, Wen Li, Yingying Li, et al.. (2018). New Acetophenone Derivatives from Acronychia oligophlebia and Their Anti‐inflammatory and Antioxidant Activities. Chemistry & Biodiversity. 15(5). e18000080–e18000080. 10 indexed citations
18.
Zhu, Xin, et al.. (2015). Novel BCOR mutation in a boy with Lenz microphthalmia/oculo-facio-cardio-dental (OFCD) syndrome. Gene. 571(1). 142–144. 15 indexed citations
19.
Yu, Yongjiang, Yu Zhang, Wenbin Guan, et al.. (2014). Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation. Molecular Cancer Research. 12(6). 830–842. 34 indexed citations
20.
Yao, Jian, Linhui Liang, Yu Zhang, et al.. (2012). GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026